Mustafa Nevzat Ilach Sanai A.Sh.,   Turkey

Powder for the preparation of solution for intramuscular administration: 1000 mg + 500 mg, 500 mg + 250 mg, 250 mg + 125 mg.

Powder for the preparation of solution for intravenous and intramuscular administration: 1000 mg + 500 mg, 500 mg + 250 mg, 250 mg + 125 mg.

Tablets coated with a film coating, 375 mg.

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 500 mg.

Primary packaging

The lyophilized powder containing 20 mg of the active ingredient is placed in a colorless glass type 3 bottle sealed with a bromobutyl rubber stopper, crimped with an aluminum ring or an aluminum cap "flip off" with plastic disc or plastic lid, over aluminum.

Solvent (water for injection): 2 ml per ampoule of colorless glass. Secondary packaging:

1 bottle with the drug and 1 ampoule with the solvent is placed in a cassette made of polyvinyl chloride; 1 cassette along with the instructions for use are placed in a cardboard box.

1 bottle with the drug and 1 ampoule with a solvent, along with instructions for use, are placed in a cardboard box.

50 bottles of the drug are placed in a cardboard box (for hospitals): with instructions for use; 50 ampoules with a solvent are placed inA separate cardboard box (for hospitals).

For 10 tablets in a blister of PVC / Al. One blister along with the instructions for use are placed in a cardboard box.

The tablets covered with a cover, on 200 and 400 mg.